A refill too soon audit finding is one of the most common triggers for a PBM recoupment demand. Most adjudication systems flag a claim automatically once a refill posts before roughly 75 percent of the prior fill's days supply has elapsed, without regard to why the pharmacy dispensed early. A dose increase, a lost bottle, a hospice transition, or a documented vacation supply can all look identical to overbilling in a claims report. The difference between a finding that gets reversed and one that becomes a recoupment is almost always the pharmacy's own file: whether the reason for the early fill was captured, in writing, at the time it happened.
How PBMs Flag Early Refills
The mechanism behind most refill too soon rejections is the NCPDP Telecommunication Standard, the electronic format pharmacies use to submit claims. A claim submitted before the payer's threshold date returns reject code 79, Refill Too Soon, or is caught by the broader reject code 88, DUR Reject Error, when a drug overuse edit finds too little of the previous supply used. During a retrospective PBM audit, the same logic runs in reverse: the auditor recalculates the gap between fills and flags any claim where the override code does not match a reason the contract recognizes. An override pushed through without a logged clinical reason is exposed later, when the pharmacist who made the call may not remember the patient.
Legitimate Grounds for an Early Refill
PBM provider manuals and state board guidance recognize a consistent set of reasons a refill can lawfully precede the standard threshold. A dose or therapy change ordered by the prescriber is one. Lost, stolen, or damaged medication is another, typically limited to one override per medication within a rolling twelve-month period and, for controlled substances, often requiring a police report. A vacation or travel supply override lets a patient obtain extra medication ahead of travel, usually capped at a set number of days per year. Hospice and long-term care settings carry their own cycle-fill and emergency-kit exceptions. Each of these survives an audit only if it was written down when it happened.
Building the Rebuttal File
A refill too soon finding is rebutted with the pharmacy's own contemporaneous records, not with an argument made for the first time in an appeal letter. The core of that file is prescriber verification: a note, callback log, or fax confirming the dose or therapy change and its effective date. Next is the pharmacist's clinical documentation, the specific clinical reason, entered in the patient profile at dispensing rather than reconstructed after an audit notice arrives. Third is the override or submission clarification code actually used, matched to the payer's own recognized reasons, since a mismatched or generic code is itself a common basis for denial. A pharmacy that can produce all three for a flagged claim is arguing from its own record, not from memory.
A refill too soon finding is rebutted with the record made at the counter, not with an explanation written after the recoupment letter arrives.
What Happens When the Rebuttal Fails
An unrebutted pattern of refill too soon findings rarely stays isolated. PBMs treat a cluster of these claims as support for extrapolation across a larger claims sample, and a pattern finding can feed into broader network conduct review, the track that leads toward network termination in serious cases. Pharmacies can review our companion pieces on how PBMs escalate from audit finding to network termination and how desk audits differ from on-site audits. An audit appeal filed with the underlying documentation before the response deadline is the pharmacy's best chance to keep a finding from becoming either outcome.
Why Early Legal Counsel Is Critical
It is critical that pharmacies retain experienced healthcare defense counsel as soon as a refill too soon finding appears on an audit report, rather than waiting until the recoupment demand follows. Early legal intervention can protect the pharmacy's rights, ensure the appeal is built on documentation the payer will credit, avoid inadvertent admissions in written responses, and preserve the pharmacy's position if the finding escalates toward extrapolation or network termination. Delaying counsel until after the appeal deadline has passed can foreclose defenses available at the outset.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies against PBM audit findings nationwide, including refill too soon recoupments and the network conduct reviews that can follow them. Our bench includes a former federal prosecutor and a former senior pharmacy benefit manager executive, background that shapes how we evaluate which flagged claims are defensible. Our work defending OptumRx audits and other national PBM reviews informs how we approach a refill too soon finding from the first notice. If your pharmacy has received a refill too soon audit finding, contact us for a free, confidential consultation.
